Gregory Sargen

This profile gathers the share dealings of Gregory Sargen across 2 companies, led by Avid Bioservices, Inc. and Cambrex Corp. We count 9 filings; the first trade dates from 11 February 2016 and the latest from 5 February 2025.

Every open-market trade on record is a sale: 3 sales worth €130k. The amount is not disclosed for 2 filings. The rest of the record consists of 1 share grant and 4 option exercises.

The record was last updated on 7 February 2025 with a transaction in Avid Bioservices, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.